Correlation between NLR and PLR with the Severity of COVID-19 Inpatients
DOI:
https://doi.org/10.24293/ijcpml.v29i1.1924Keywords:
Neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, the severity degree of COVID-19Abstract
When the COVID-19 outbreak is ongoing, the classification of COVID-19 patients based on the severity assessment is necessary to optimize the allocation of existing resources and early management interventions to improve prognosis. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) are two of the most common, simple, inexpensive, rapid, and widely available tests in all health facilities, which indirectly indicate the inflammatory status of COVID-19 patients. This study aimed to analyze the correlation between NLR and PLR with the severity of COVID-19 inpatients. This cross-sectional study was conducted retrospectively using medical record data of COVID-19 patients hospitalized at Al Islam Hospital, Bandung, from January to March 2021. COVID-19 patients involved in this study were classified into moderate, severe, and critical degrees. Statistical analysis was carried out using ANOVA or Kruskal-Wallis and Spearman with a significant value of p < 0.05. The median NLR and PLR results based on the severity were 3.49; 6.27; 8.4 (p<0.001) and 159.2; 202.6; 250.9 (p<0001), respectively. There was a correlation between NLR and PLR and the severity with r= 0.415 (p<0.001) and r=0.216 (p<0.001), respectively. The correlation between NLR and the severity was stronger than PLR. Therefore, it was concluded that there was a correlation between NLR and PLR with the severity of COVID-19 patients.
Downloads
References
Di Gennaro F, Pizzol D, Marotta C, Antunes M, Rocalbuto V, et al. Coronavirus Diseases (COVID-19)
current status and future perspectives: A narrative review. International Journal of Environmental
Research and Public Health, 2021; 17: 2690.
World Health Organization. WHO. [Online], 2021. Available from:https://www.who.int/health-topics/
coronavirus#tab=tab_1 (accessed 5 April, 2021).
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Napoli RD. Features, evaluation, and treatment of Coronavirus (COVID-19). [Online], 2021. Available from:https ://www.ncbi .nlm.nih.gov /books /
NBK554776/ (accessed 6 August 2021).
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19) A review. JAMA, 2020; 324(8): 782-793.
Selanno Y, Widaningsih Y, Esa T, Arif M. Analysis of neutrophil lymphocyte ratio and absolute lymphocyte count as predictors of severity of COVID-19 patients. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2021; 27(2): 184-189.
Tsai PH, Lai WY, Lin YY, Luo YH, Lin YT, et al. Clinical manifestation and disease progression in COVID-19 infection. Journal of the Chinese Medical Association, 2021; 84(1): 3-8.
Yuliana. Coronavirus Disease (COVID-19); Sebuah tinjauan literatur. Wellness and Healthy Magazine,
; 2(1): 187-192.
Setiati S, Azwar MK. COVID-19 and Indonesia. Acta Medica Indonesiana, 2020; 52(1): 84-89.
Kementerian Kesehatan Republik Indonesia. Infeksi Emerging. [Online], 2021. Available from: https://
infeksiemerging.kemkes.go.id/situasi-infeksi- e m e rgi ng/ s it u a s i - t e r k i n i -pe r k e m ba nga n
-coronavirus-disease-covid-19-30-april-2021 (accessed 7 May, 2021).
Yamamoto K, Ohmagari N. Microbiological testing for Coronavirus disease 2019. JMA Journal, 2021; 4(2): 67-75.
Permana A, Yari CE, Aditya AK. Gambaran D-dimer dan limfosit pada pasien terkonfirmasi COVID-19 di RS Haji Jakarta. Jurnal Ilmiah Analisis Kesehatan, 2021; 7(1): 62-71.
Terpos E, Stathopoulos IN, Elalamy I, Kastritis E, Sergentanis TN, et al. Hematological findings and
complications of COVID-19. Am J Hematol, 2020; 95(7): 834-847.
Chan AS, Rout A. Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19. J Clin Med Res and Elmer Press Inc, 2020; 12(7): 448-453.
Henry BM, Oliveira HSd, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in Coronavirus Disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med, 2020; 58(7): 1021-1028.
Man MA, Rajnoveanu RM, Motoc NS, Bondor CI, Chis AF, et al. Neutrophil-to-lymphocyte ratio,
platelets-to-lymphocyte ratio, and eosinophils correlation with high-resolution computer tomography severity score in COVID-19 patients. PLos One, 2021; 16(6): 1-12.
Riandy MD, Purba BA, Puspita Y, Zainal R, Siswo L. Hubungan rasio neutrofil limfosit dengan mortalitas ≤ 28 hari di General Intensive Care Unit RSUP Dr. Mohammad Hoesin Palembang. Jurnal Anestesi Perioperatif, 2019; 7(3): 188-197.
Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Elsevier Public Health Emergency Collection, 2020; 84: 106504.
Jain R, Gopal A, Pathak BK, Mohakuda SS, Tilak T, Singh AR. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio and their role as predictors of disease severity of Coronavirus Disease 2019
(COVID-19). Journal of Laboratory Physicians, 2021; 13(1): 58-63.
Qu R, Ling Y, Zhang YHZ, Wei LY, Chen X, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with Coronavirus disease-19. Journal of Medical Virology Wiley, 2020; 1-9.
Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S, et al. Inactivation of three emerging viruses–severe acute respiratory syndrome coronavirus, Crimean–Congo haemorrhagic fever
virus and Nipah virus–in platelet concentrates by ultraviolet C light and in plasma by methylene blue
plus visible light. Vox Sanguinis, 2020; 115: 146-151.
Rahman A, Shanjana Y, Tushar I, Mahmud T, Rahman GMS, et al. Hematological abnormalities and
comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from
Bangladesh. PLos One, 2021; 16(7): 1-16.
Zhu B, Feng X, Jiang C, Mi S, Yang L, et al. Correlation between white blood cell count at admission and mortality in COVID-19 patients: A retrospective study. BMC Infectious Disease, 2021; 21(1): 574.
S, Wijaya I, Dalimoenthe NZ. The correlation of neutophil - to- lymphocyte ratio (NLR) and monocytes-to-lymphocytes ratio (MLR) with disease severity in hospitalized paatients with Coronavirus
Disease 2019 (COVID-19). Bali Medical Journal, 2021; 10(2): 653-658.
Jin JM, Bai P, He W, Wu F, Liu XF, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers in Public Health, 2020; 8: 152.
Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, et al. Sex differences in susceptibility, severity, and outcomes of Coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PLos One, 2021; 16(1): 1-14.
Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature, 2020; 588(7837): 315-320.
Cai Y, Kim DJ, Takahashi T, Broadhurst DI, Ma S, et al. Kynurenic acid underlies sex-specific immune
responses to COVID-19. [Online], 2020. Available fro m : h ttps ://www. m edr x i v .org/ con t e n t/
1101/2020.09.06.20189159v2.full.pdf (accessed 21 June, 2021).
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Annals of Hematology, 2020; 99(6): 1205-1208.
Wu C, Chen X, Cai Y, Xia J, Zhou X, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 2020; 180(7): 934-943.
Reusch N, Domenico ED, Bonaguro L, Schrepping JS, Babler K, et al. Neutrophils in COVID-19. frontiers in Immunology, 2021; 12: 1-9.
Shahri MK, Niazkar HR, Rad F. COVID-19 and hematology findings based on the current eviences: A puzzle with many missing pieces. International Journal of Laboratory Hematology, 2021; 43(2): 160-168.
Zhang D, Guo R, Lei L, Liu H, Wang Y, et al. Frontline science: COVID-19 infection induces readily
detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes.
Journal of Leukocyte Biology, 2021; 109(1): 13-22.
Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: Interaction effect with disease severity a retrospective study. BMJ Open, 2019; 9(1): 1-7.
Qun S, Wang Y, Chen J, Huang X, Guo H, Lu Z, et al. Neutrophil-to-lymphocyte ratios are closely
associated with the severity and course of non-mild COVID-19. Frontiers in Immunology, 2020; 11: 1-11.
Palladino M. Complete blood count alterations in COVID-19 patients: A narrative review. Biochemica
Medica, 2021; 31(3): 1-13.
Forget P, Khalifa C, Defour JP, Latinne D, Pel MCV, Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res Notes, 2017; 10: 12.
Lamichhane PP, Samarasinghe AE. The role of innate leukocytes during influenza virus infection. Journal of Immunology Research, 2019; Article ID 8028725: 17.
Borges L, Curi TCP, Curi R, Hatanaka E. COVID-19 and neutrophils: The relationship between hyperinflammation and neutrophil extracellular traps. [Online], 2020. Available from: https://doi.
org/10.1155/ 2020/8829674 (accessed 20 July, 2021).
Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early transmission dynamics in Wuhan, China, of novel
Coronavirus–infected pneumonia. The New England Journal of Medicine, 2020; 382: 1199-1207.
Rayes J, Bourne JH, Brill A, Watson SP. The dual role of platelet-innate immune cell interactions in thromboinflammation. WILEY, 2019; 4(1): 23-35.
Sarkar S, Kannan S, Khanna P, Singh AK. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Virology, 2021; 1-11.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
